Cefadroxil: Clinical Trials

5 trials of Cefadroxil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Enrolling by invitation 1, Recruiting 1, Terminated 1

Follow Cefadroxil: new trials by email Literature Review of Cefadroxil trials Research Report on Cefadroxil

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients
Cefadroxil 500 mg Capsules, Clindamycin, Bactrim DS - Fracture Lower Leg, Diabetes
Phase 4RecruitingTexas Tech University Health Sciences Center, El Paso402026-04-012026-05-08
Comparing Oral Versus Parenteral Antimicrobial Therapy
Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection
Phase 4TerminatedWest Virginia University942023-08-042025-08-26
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Cephalexin, Doxycycline, Cefadroxil - Infections Joint Prosthetic, Overweight or Obesity
Phase 4Enrolling by invitationMayo Clinic46182020-06-112026-07-06
A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects
Cefadroxil tablets manufactured by GSK, Cefadroxil tablets manufactured by NP - Infections, Urinary Tract
Phase 4CompletedGlaxoSmithKline242014-03-312017-09-21
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Cefadroxil discontinued early, Cefadroxil until drain removal - Bacterial Infection, Anti-infective Agents
Phase 4CompletedStony Brook University1322010-11-012014-05-13

Conditions studied

Diabetes Mellitus (2)  ·  Autoimmune Diseases (1)  ·  Bacterial Infections (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Renal Insufficiency, Chronic (1)  ·  Soft Tissue Infections (1)  ·  Surgical Wound Infection (1)  ·  Tobacco Use (1)  ·  Urinary Tract Infections (1)

Sponsors

GlaxoSmithKline (1)  ·  Mayo Clinic (1)  ·  Stony Brook University (1)  ·  Texas Tech University Health Sciences Center, El Paso (1)  ·  West Virginia University (1)

Countries

United States (4)  ·  Egypt (1)

Top investigators

Arif R. Sarwari, MD, MSc, MBA (1)  ·  Brett T Phillips, MD (1)  ·  Duc T Bui, MD (1)  ·  Joy J. Juskowich, MD (1)  ·  Nicholas Bedard, MD (1)

Results publications

PMID 27106640, PMID 41419216